Studies have also shown that IGFBP4 interferes with the E2-induced activation of the Akt/PKB pathway and prevents fully hormone-dependent activation of ERα and breast cancer cell growth in an IGF- and IGF-IR-independent manner [45]. Here, IGFBP4 is linked to breast cancer.